Guardant Health

YTD

ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection.

CEO

Helmy Eltoukhy

CEOHelmy Eltoukhy

Employees

2,021

Employees2,021

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2011

Founded2011

Employees

2,021

Employees2,021

GH Key Statistics

Market cap

11.51B

Market cap11.51B

Price-Earnings ratio

-21.60

Price-Earnings ratio-21.60

Dividend yield

—

Dividend yield—

Average volume

2.48M

Average volume2.48M

High today

$95.88

High today$95.88

Low today

$88.00

Low today$88.00

Open price

$89.98

Open price$89.98

Volume

6.41M

Volume6.41M

52 Week high

$95.88

52 Week high$95.88

52 Week low

$21.28

52 Week low$21.28

GH News

TipRanks 21h

Guardant Health reports Q3 EPS (39c), consensus (49c)

Reports Q3 revenue $265.2M, consensus $235.7M. “This was an exceptional quarter for Guardant with broad-based growth across our business,” said Helmy Eltoukhy,...

Investor's Business Daily 21h

Why IBD 50's Guardant Health, Up 137% in 2025, Could Surge Again

Guardant Health (GH) on Wednesday posted results that smashed Wall Street's third-quarter expectations. The Palo Alto, Calif.-based company is best-known for i...

Simply Wall St 4d

Could Guardant Health's Expansive ESMO 2025 Data Redefine Its Long-Term Innovation Edge?

Guardant Health announced that it recently presented new data from 15 oncology studies spanning multiple cancer types at the European Society for Medical Oncolo...

Analyst ratings

88%

of 26 ratings

Buy

88.5%

Hold

7.7%

Sell

3.8%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.